Caribou Biosciences, Inc.
CRBU
$1.96
$0.0753.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.34% | 13.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.34% | 13.29% | |||
| Cost of Revenue | -25.53% | -94.16% | |||
| Gross Profit | 124.43% | 102.20% | |||
| SG&A Expenses | 6.86% | -7.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.84% | 12.18% | |||
| Operating Income | 17.44% | -12.12% | |||
| Income Before Tax | -35.28% | -12.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.28% | -12.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.28% | -12.68% | |||
| EBIT | 17.44% | -12.12% | |||
| EBITDA | 17.93% | -12.56% | |||
| EPS Basic | -34.76% | -10.84% | |||
| Normalized Basic EPS | -4.49% | -12.33% | |||
| EPS Diluted | -34.76% | -10.84% | |||
| Normalized Diluted EPS | -4.49% | -12.33% | |||
| Average Basic Shares Outstanding | 0.38% | 1.67% | |||
| Average Diluted Shares Outstanding | 0.38% | 1.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||